Order Article Reprints

Castaño-Díez S, López-Guerra M, Bosch-Castañeda C, Bataller A, Charry P, Esteban D, Guijarro F, Jiménez-Vicente C, Castillo-Girón C, Cortes A, et al. Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes. Cancers. 2022; 14(17):4107. https://doi.org/10.3390/cancers14174107

Castaño-Díez, Sandra, Mónica López-Guerra, Cristina Bosch-Castañeda, Alex Bataller, Paola Charry, Daniel Esteban, Francesca Guijarro, Carlos Jiménez-Vicente, Carlos Castillo-Girón, Albert Cortes, and et al. 2022. "Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes" Cancers 14, no. 17: 4107. https://doi.org/10.3390/cancers14174107

Castaño-Díez, S., López-Guerra, M., Bosch-Castañeda, C., Bataller, A., Charry, P., Esteban, D., Guijarro, F., Jiménez-Vicente, C., Castillo-Girón, C., Cortes, A., Martínez-Roca, A., Triguero, A., Álamo, J. R., Beà, S., Costa, D., Colomer, D., Rozman, M., Esteve, J., & Díaz-Beyá, M. (2022). Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes. Cancers, 14(17), 4107. https://doi.org/10.3390/cancers14174107